Nauman Wazir & Shafqat Ur Rehman. (2022). Efficacy and Safety of Empagliflozin as Add-On Therapy in Patients of Type-2 Diabetes Mellitus. Gandhara University.
Chicago Style (17th ed.) CitationNauman Wazir and Shafqat Ur Rehman. Efficacy and Safety of Empagliflozin as Add-On Therapy in Patients of Type-2 Diabetes Mellitus. Gandhara University, 2022.
MLA (9th ed.) CitationNauman Wazir and Shafqat Ur Rehman. Efficacy and Safety of Empagliflozin as Add-On Therapy in Patients of Type-2 Diabetes Mellitus. Gandhara University, 2022.
Warning: These citations may not always be 100% accurate.